JP2023501720A5 - - Google Patents

Info

Publication number
JP2023501720A5
JP2023501720A5 JP2022528256A JP2022528256A JP2023501720A5 JP 2023501720 A5 JP2023501720 A5 JP 2023501720A5 JP 2022528256 A JP2022528256 A JP 2022528256A JP 2022528256 A JP2022528256 A JP 2022528256A JP 2023501720 A5 JP2023501720 A5 JP 2023501720A5
Authority
JP
Japan
Prior art keywords
target
independently
drugs
amino acid
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022528256A
Other languages
English (en)
Japanese (ja)
Other versions
JP7908864B2 (ja
JP2023501720A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/061127 external-priority patent/WO2021102052A1/en
Publication of JP2023501720A publication Critical patent/JP2023501720A/ja
Publication of JP2023501720A5 publication Critical patent/JP2023501720A5/ja
Application granted granted Critical
Publication of JP7908864B2 publication Critical patent/JP7908864B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022528256A 2019-11-18 2020-11-18 指向性コンジュゲーション技術 Active JP7908864B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962937131P 2019-11-18 2019-11-18
US62/937,131 2019-11-18
US202063063902P 2020-08-10 2020-08-10
US63/063,902 2020-08-10
PCT/US2020/061127 WO2021102052A1 (en) 2019-11-18 2020-11-18 Directed conjugation technologies

Publications (3)

Publication Number Publication Date
JP2023501720A JP2023501720A (ja) 2023-01-18
JP2023501720A5 true JP2023501720A5 (enExample) 2023-11-24
JP7908864B2 JP7908864B2 (ja) 2026-08-20

Family

ID=

Similar Documents

Publication Publication Date Title
JP2022532134A5 (enExample)
AU2017225111B2 (en) Modified antibody regions and uses thereof
TWI886164B (zh) 1價ccap生成物之製造方法
JP2024521092A5 (enExample)
JP2002513795A (ja) モノマー、オリゴマーおよびポリマーのクネベナーゲル縮合生成物
JP2021508449A5 (enExample)
JP7605290B2 (ja) 化合物またはその塩、およびそれらにより得られる抗体
KR20220110209A (ko) 이중 il-2r 및 il-7r 결합 화합물
WO2023281484A1 (en) Synthetic il-7 and il-7 immunocytokines
CN111971060A (zh) 募集抗体并靶向肿瘤细胞的双功能分子
Kimmel et al. Solid-phase synthesis of megamolecules
WO2023054714A1 (ja) 抗体および機能性物質の位置選択的なコンジュゲートまたはその塩、ならびにその製造に用いられる抗体誘導体および化合物またはそれらの塩
JP2021535108A5 (enExample)
AU2026202991A1 (en) Compound or salt thereof, and antibody produced using same
WO1994020521A1 (de) Verfahren zur synthese und selektionierung von sequenzen aus kovalent verbundenen bausteinen
WO2024210154A1 (ja) 抗体および機能性物質のコンジュゲート、抗体誘導体ならびに化合物、またはそれらの塩
TW202214307A (zh) 奈米脂蛋白－多肽結合物及組成物、系統及其使用方法
DE69423753T2 (de) Polyoximverbindungen und deren herstellung
JP7670072B2 (ja) 化合物またはその塩、およびそれらにより得られる抗体
PT1817342E (pt) Método de purificação por afinidade
JP2024519031A5 (enExample)
CN118742329A (zh) 包含抗组织因子抗体-药物缀合物的药物组合物
JP2024516392A5 (enExample)
US20240148877A1 (en) Synthetic Strategy to Polymerize Protein into Molecularly Defined Polymers
JP2012522021A (ja) 合成ペプチド及びその応用